Bank of Montreal’s China SXT Pharmaceuticals SXTC Stock Holding History

Bank of Montreal’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8	Closed	-$5.08K	–	3734
2024 Q4	$5.08K	Hold	8	–	–	﹤0.01%	3397
2024 Q3	$6.42K	Hold	8	–	–	﹤0.01%	3696
2024 Q2	$12.5K	Buy	+8	New	+$11.3K	﹤0.01%	3637

Other funds holding SXTC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal's SXTC Position: Q1 2025 in Review

Bank of Montreal sold out of China SXT Pharmaceuticals (SXTC) in Q1 2025, closing a stake of 8 shares — an estimated $5.08K sold.

Bank of Montreal first reported a position in SXTC in Q2 2024 and held it in 3 quarters. The position peaked at $12.5K in Q2 2024. 1 fund tracked by Wall St. Rank holds SXTC as of Q1 2025.

Bank of Montreal reported no remaining China SXT Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Bank of Montreal sold 8 China SXT Pharmaceuticals shares in Q1 2025, an estimated $5.08K.
Bank of Montreal first reported a position in China SXT Pharmaceuticals in Q2 2024 and held it in 3 quarters.
Bank of Montreal's China SXT Pharmaceuticals position peaked at $12.5K in Q2 2024.
1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.